REG - Vulcan Two Group PLC - Completion of Acquisitions and Re-Admission

Vulcan TwoAnnouncement

19/03/2026 08:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260319:nRSS3075Xa&default-theme=true

RNS Number : 3075X  Vulcan Two Group PLC  19 March 2026

19 March 2026

Vulcan Two Group plc

(the "Company")

 

Completion of Acquisitions,

Completion of Placing and

Re-admission to trading

 

Vulcan Two Group plc, the company aiming to create the UK's leading regulated
ePharmacy through buy-and-build, is pleased to announce that, further to the
announcement on 26 February 2026 (the "Launch Announcement"), it has now
completed the acquisition of CloudRx, Hyperdrug and Webmed (the "Targets").
The Company has also completed an institutional Placing for £40 million, the
detail of which was included in the Launch Announcement.

 

The acquisition of the Targets, individually and collectively, constituted a
Reverse Takeover pursuant to Rule 14 of the AIM Rules for Companies.
Accordingly, having received shareholder approval at a General Meeting on 17
March 2026, the Company's existing Ordinary Shares were re-admitted to trading
on AIM at 8.00 a.m. this morning, alongside the new Ordinary Shares issued
pursuant to the Placing and the Acquisitions ("Re-admission").

 

Directorate Changes

 

As set out in the Launch Announcement, Keith Butcher has been appointed to the
Company's Board of Directors with effect from Re-admission.

 

Total Voting Rights

 

Following Re-admission, the Company's total issued share capital now consists
of 27,275,000 Ordinary Shares. This figure may be used by shareholders in the
Company as the denominator for the calculations by which they will determine
if they are required to notify their interest in, or a change in their
interest in, the share capital of the Company under the Financial Conduct
Authority's Disclosure Guidance and Transparency Rules.

 

Other than where defined, capitalised terms used in this announcement have the
meanings given to them in the Launch Announcement.

 

For further information please contact:

 Vulcan Two Group plc                                      Email: info@vulcantwo.com (mailto:info@vulcantwo.com)

 Michael Kraftman, Chief Executive Officer

 Brendan O'Brien, Chief Operating Officer

 Keith Butcher, Chief Financial Officer

 www.vulcantwo.com (http://www.vulcantwo.com/)
 Canaccord Genuity Limited                                 Tel: +44 (0) 20 7523 8000

(Nominated Adviser and Sole Broker)

 Simon Bridges / Harry Pardoe / Elizabeth Halley-Stott
 Alma Strategic Communications                             Email: vulcantwo@almastrategic.com (mailto:vulcantwo@almastrategic.com)

(Financial PR)

                                                         Tel: +44 (0) 20 3405 0205
 Justine James / Sam Modlin / Will Merison

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  FURSFUSAUEMSESD



            Copyright 2019 Regulatory News Service, all rights reserved